Events

4th Annual Immuno-Oncology BD&L and Investment Forum

Dr. Jonathan Bramson to be presenting at 3:20 p.m. CT on June 1.

At the IOBDLI Forum, Triumvira Scientific Founder and Acting Chief Scientific Officer, Dr. Jonathan Bramson, will provide an overview of the company’s T Cell-Antigen Coupler (TAC) technology ...
Read more »

2018 BIO International Convention

Triumvira President and Chief Executive Officer, Dr. Paul Lammers available for private meetings June 4-5

At BIO International, Triumvira Immunologics President and Chief Executive Officer, Dr. Paul Lammers will be available for private meetings during the day on June 4-5 to discuss potential coll ...
Read more »

International Society for Cellular Therapy 2018

Triumvira will be presenting at ISCT 2018 – May 2-5, 2018 at the Palais des Congrès de Montréal in Montréal, QC, Canada

ISCT is the premier cell therapy translation society focused on pre-clinical, clinical and translational aspects of developing cell therapy products. As such, ISCT helps academic, government ...
Read more »

Bloom Burton & Co. Healthcare Investor Conference

Triumvira will be presenting at the Bloom Burton & Co. Healthcare Investor Conference on May 2 and 3, 2018 at the Sheraton Centre Toronto Hotel in Toronto, ON., Canada

This year, BBHIC will host approximately 60 of Canada’s premier publicly-traded and venture-backed private companies together with the most promising pre-venture companies in the healthcare ...
Read more »